Literature DB >> 28523556

Epigenetics in Parkinson's Disease.

Maria Angeliki S Pavlou1,2, Tiago Fleming Outeiro3,4,5.   

Abstract

Parkinson's disease (PD) is a highly complex neurodegenerative disorder with a multifactorial origin. Although several cellular mechanisms and genes have been implicated in the onset and progression of the disease, the precise molecular underpinnings of the disease remain unclear. In this context, epigenetic modulation of gene expression by environmental factors is emerging as an important mechanism in PD and in other neurodegenerative disorders. Thus, epigenetic mechanisms, such as DNA methylation, histone modifications and altered microRNA expression, have been under intense investigation due to their possible involvement in PD. Epigenetic modulation is responsible for inducing differential gene expression, a phenomenon which is essential throughout life in order to regulate multiple cellular responses such as development, cellular fate commitment and adaptation to the environment. Disturbances of a balanced gene expression can, therefore, have detrimental effects. Environmental factors can challenge the establishment and maintenance of epigenetic modifications and could thereby fill the gap in our further understanding of origin and/or progression of neurodegenerative diseases. In this chapter, we focus on the role of epigenetics in PD.

Entities:  

Keywords:  Alpha-synuclein; DNA methylation; Epigenetics; Histone modifications; Parkinson’s disease; miRNA

Mesh:

Substances:

Year:  2017        PMID: 28523556     DOI: 10.1007/978-3-319-53889-1_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

1.  Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.

Authors:  Umut Cagin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Nut1/Hos1 and Sas2/Rpd3 control the H3 acetylation of two different sets of osmotic stress-induced genes.

Authors:  María E Pérez-Martínez; Marta Benet; Paula Alepuz; Vicente Tordera
Journal:  Epigenetics       Date:  2019-09-12       Impact factor: 4.528

3.  DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood.

Authors:  Adrienne Henderson-Smith; Kathleen M Fisch; Jianping Hua; Ganqiang Liu; Eugenia Ricciardelli; Kristen Jepsen; Mathew Huentelman; Gabriel Stalberg; Steven D Edland; Clemens R Scherzer; Travis Dunckley; Paula Desplats
Journal:  Epigenetics       Date:  2019-03-14       Impact factor: 4.528

Review 4.  Tet Enzymes-Mediated DNA 5hmC Modification in Cerebral Ischemic and Hemorrhagic Injury.

Authors:  Xiaohua Ma; Bo Yang; Xiaojing Li; Zhigang Miao
Journal:  Neurotox Res       Date:  2022-04-08       Impact factor: 3.911

Review 5.  The role of histone modifications: from neurodevelopment to neurodiseases.

Authors:  Jisu Park; Kyubin Lee; Kyunghwan Kim; Sun-Ju Yi
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

Review 6.  The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.

Authors:  Zixuan Chen; Madiha Rasheed; Yulin Deng
Journal:  Brain Pathol       Date:  2021-08-20       Impact factor: 7.611

Review 7.  Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies.

Authors:  Ines Banjari; Tihana Marček; Svetlana Tomić; Viduranga Y Waisundara
Journal:  Front Nutr       Date:  2018-10-30

Review 8.  Epigenetics in neurodegenerative disorders induced by pesticides.

Authors:  Guangxia Yu; Qianqian Su; Yao Chen; Lingyan Wu; Siying Wu; Huangyuan Li
Journal:  Genes Environ       Date:  2021-12-10

Review 9.  Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Sokratis G Papageorgiou; Christina Piperi
Journal:  Brain Sci       Date:  2022-01-28

10.  Minimotifs dysfunction is pervasive in neurodegenerative disorders.

Authors:  Surbhi Sharma; Richard J Young; Jingchun Chen; Xiangning Chen; Edwin C Oh; Martin R Schiller
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.